Altimmune, Inc.ALTNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-67.84M
↓ 171% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-25.04M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-67.84M | +15.0% |
| 2024 | $-79.85M | -5.3% |
| 2023 | $-75.86M | -21.0% |
| 2022 | $-62.71M | +30.7% |
| 2021 | $-90.55M | -161.3% |
| 2020 | $-34.65M | -260.8% |
| 2019 | $-9.60M | +7.7% |
| 2018 | $-10.40M | +48.9% |
| 2017 | $-20.38M | -110.1% |
| 2016 | $201.48M | - |